
Tag Archives: CMS
Screws Tighten on 340B Program
http://healthleadersmedia.com/content.cfm?topic=HEP&content_id=324594##
A MedPAC recommendation to reduce by 10% Medicare payment rates for 340B hospitals’ separately payable Part B drugs has been greeted with a chorus of boos from hospital trade associations.
Medicare Part D’s Importance Extends Far Beyond The Drug Benefit It Provides
Experts predict reimbursement changes for 2016
Reflections from Health Republic’s top exec as business winds down
Health Affairs Web First: Access To Care In The US Rose 3.4 Percentage Points Since ACA Implementation
Implementation Of The Biosimilars Provisions Of The ACA — Where Are We Now?
CMS Penalizes 758 Hospitals Over Hospital-Acquired Conditions
340B will go through big transition in 2016

HRSA’s authority to oversee the program is being challenged









